SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-097767
Filing Date
2017-03-27
Accepted
2017-03-27 17:00:59
Documents
4
Effectiveness Date
2017-03-27

Document Format Files

Seq Description Document Type Size
1 DFAN14A d433703ddfan14a.htm DFAN14A 22541
2 GRAPHIC g4337031new.jpg GRAPHIC 78136
3 GRAPHIC g4337032new.jpg GRAPHIC 477077
4 GRAPHIC g4337033new.jpg GRAPHIC 566951
  Complete submission text file 0001193125-17-097767.txt   1558536
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Subject) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 000-30319 | Film No.: 17715976
SIC: 2834 Pharmaceutical Preparations

Mailing Address 660 STEAMBOAT ROAD GREENWICH CT 06830
Business Address 660 STEAMBOAT ROAD GREENWICH CT 06830 203-302-2330
Sarissa Capital Management LP (Filed by) CIK: 0001577524 (see all company filings)

IRS No.: 900924432 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A